Antigen presenting system and methods for activation of T-cells
AssigneeThe Scripps Research Institute
InventorsZeling Cai, Jonathan Sprent, Anders Brunmark, Michael Jackson, Per A. Peterson
Life of this patent
Estimating the term…
Abstract
Materials and methods for activating T lymphocytes with specificity for particular antigenic peptides are described, as well as the use of activated T lymphocytes in vitro for the treatment of a variety of disease conditions. In particular, a method for producing a synthetic antigen presenting cell line for activating T lymphocytes to a specific peptide is described.
Claims22
A synthetic antigen presenting cell line for activating T-cell lymphocytes to a specific peptide and comprising:
- a) a Class I MHC heavy chain gene operably linked to a first promoter, said gene expressing a Class I MHC heavy chain;
- b) a β-2 microglobulin gene operably linked to a second promoter, said gene expressing a β-2 microglobulin that forms a MHC molecule with the MHC heavy chain;
- and
- c) a gene for an assisting molecule operably linked to a third promoter, said gene expressing an assisting molecule which is a member of the group consisting of B7.1, B7.2, ICAM-1, ICAM-2, ICAM-3 and LFA-3, and that interacts with a molecule on the T-cell lymphocytes;
- with the proviso that at least one of said MHC gene, said β-2 microglobulin gene and said assisting molecule gene is not present in the cells from which the cell line is derived, such that the MHC molecule binds to a peptide, and the MHC molecule and the assisting molecule are presented on the surface of an insect cell of said cell line in sufficient numbers to activate a population of T-cell lymphocytes against the peptide when the peptide is bound to the MHC molecule.
A stable poikilotherm cell line used to stimulate human T-cell lymphocytes comprising:
- a) a Class I MHC gene operably linked to a first inducible promoter, said gene expressing a Class I MHC heavy chain;
- b) a β-2 microglobulin gene operably linked to a second promoter, said gene expressing a β-2 microglobulin that forms a MHC molecule with the MHC heavy chain;
- and
- c) a gene for an assisting molecule operably linked to a third promoter, said gene expressing an assisting molecule which is a member of the group consisting of B7.1, B7.2, ICAM-1, ICAM-2, ICAM-3 and LFA-3, and that interacts with a molecule on the T-cell lymphocytes;
- such that a cell of the cell line assembles empty MHC molecules that bind to a peptide, and the MHC molecule and the assisting molecule are presented on the surface of a cell of the cell line in sufficient numbers to activate a population of T-cell lymphocytes against the peptide when the peptide is bound to the MHC molecule.
A stable poikilotherm cell line used to stimulate human T-cell lymphocytes comprising:
- a) a Class I MHC gene operably linked to a first promoter, said gene expressing a Class I MHC heavy chain;
- b) a β-2 microglobulin gene operably linked to a second promoter, said gene expressing a β-2 microglobulin that forms a MHC molecule with the MHC heavy chain;
- and
- c) a gene for a costimulatory molecule operably linked to a third promoter and said gene expressing a costimulatory molecule which is a B7.1 molecule or a B7.2 molecule that interacts with a molecule on the T-cell lymphocytes;
- d) a gene for an adhesion molecule operably linked to a fourth promoter and said gene expressing an adhesion molecule that interacts with a cooperative adhesion molecule on the T-cell lymphocytes and is a member of the group consisting of ICAM-1, ICAM-2, ICAM-3 and LFA-3.
- such that the cell is capable of assembling the MHC heavy chain and the β-2 microglobulin into a MHC molecule that binds to a peptide, and transporting MHC molecule, costimulatory molecule and adhesion molecule to the surface of the cell in sufficient numbers to activate a population of T-cell lymphocytes against the peptide when the peptide is bound to the MHC molecule.
Dependencies are inferred from the claim text.